Top

Published in:

01-12-2009 | Original Paper

Membrane saturated fatty acids and disease progression in Multiple Sclerosis patients

Authors: G. M. Hon, M. S. Hassan, S. J. van Rensburg, S. Abel, R. T. Erasmus, T. Matsha

Published in: Metabolic Brain Disease | Issue 4/2009

Abstract

The risk of developing multiple sclerosis is associated with increased dietary intake of saturated fatty acids. We determined the fatty acid composition within the different phospholipid fractions of red blood and peripheral blood mononuclear cell membranes of 31 patients diagnosed with multiple sclerosis and 30 healthy control subjects using gas chromatography. Individual saturated fatty acids were correlated with the severity of neurological outcome as measured by the Kurtzke Expanded Disability Status Scale. Significant increases were found in multiple sclerosis peripheral blood mononuclear cell membrane sphingomyelin C14:0 and phosphatidylinositol C22:0. In the peripheral blood mononuclear cell membranes, C22:0 and C24:0 showed positive correlations, while C14:0, C16:0 and C20:0 showed inverse correlations with the Functional System Scores. In conclusion, this study is in accordance with previous studies that have shown an increase in shorter long-chain SATS in MS patients. In addition, this study also showed that higher C14:0 and C16:0 reflected better disease outcome as demonstrated by the inverse correlation with the EDSS and FSS. We have also characterized the specific SATS, that is, long-chain SATS that may increase the risk of developing MS.

Antonovsky A, Leibowitz U, Smith HA, Medalie JM, Balogh M, Kats R, Halpern L, Alter M (1965) Epidemiologic study of multiple sclerosis in Israel. Arch Neurol 13:183–193PubMed

Boggs JM, Moscarello MA (1980) A comparison of composition and fluidity of multiple sclerosis and normal myelin. Neurochem Res 5:319–336CrossRefPubMed

Brown KA (2001) Factors modifying the migration of lymphocytes across the blood-brain barrier. Int Immunopharmacol 1:2043–2062CrossRefPubMed

Brück W (2005) Clinical implications of neuropathological findings in multiple sclerosis. J Neurol 252:III/10–III/14CrossRef

Butcher PJ (1986) Milk consumption and multiple sclerosis—an etiological hypothesis. Med Hypotheses 19:169–178CrossRefPubMed

Cendrowski W, Wender M, Dominik W, Flejsierowicz Z, Owsianowski M, Popiel M (1969) Epidemiological study of multiple sclerosis in Western Poland. Eur Neurol 2:90–108CrossRefPubMed

Cherayil GD (1984) Sialic acid and fatty acid concentrations in lymphocytes, red blood cells and plasma from patients with multiple sclerosis. J Neurol Sci 63:1–10CrossRefPubMed

Cooper RL (1997) Multiple sclerosis: an immune legacy? Med. Hypotheses 49:307–311CrossRef

Cordo SM, Candurra NA, Damonte EB (1999) Myristic acid analogs are inhibitors of Junin virus replication. Microb Infect 1:609–614CrossRef

Cunnane SC, Ho S-Y, Dore-Duffy P, Ells KR, Horrobin DF (1989) Essential fatty acid and lipid profiles in plasma and erythrocytes in patients with multiple sclerosis. Am J Clin Nutr 50:801–806PubMed

Folch J, Lees M, Sloane-Stanley GH (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497–509PubMed

German JB, Dillard CJ (2004) Saturated fats: what dietary intake? Am J Clin Nutr 80:550–559PubMed

Grand RJA (1989) Acylation of viral and eukaryotic proteins. Biochemistry 258:625–638

Harbige LS, Sharief MK (2007) Polyunsaturated fatty acids in the pathogenesis and treatment of multiple sclerosis. Br J Nutr 98:S46–S53CrossRefPubMed

Holman RT, Johnson SB, Kokmen E (1989) Deficiencies of polyunsaturated fatty acids and replacement by nonessential fatty acids in plasma lipids in multiple sclerosis. Proc Natl Acad Sci USA 86:4720–4724CrossRefPubMed

Hon GM, Hassan MS, Van Rensburg SJ, Abel S, De Marais W, Van Jaarsveld P, Smuts CM, Henning F, Erasmus RT, Matsha T (2009a) Erythrocyte membrane fatty acids in patients with multiple sclerosis. Mult Scler 15:759–762CrossRefPubMed

Hon G, Hassan M, Van Rensburg SJ, Abel S, Marais DW, Van Jaarsveld P, Smuts C, Henning F, Erasmus R, Matsha T (2009b) Immune cell membrane fatty acids and inflammatory marker, C-reactive protein, in patients with multiple sclerosis. Br J Nutr 19:1–7

Hunter SF, Hafler DA (2000) Ubiquitous pathogens. Links between infection and autoimmunity in MS? Neurology 55:164–165PubMed

Kaushal V, Barnes LD (1986) Effect of zwitterionic buffers on measurement of small masses of protein with bicinchoninic acid. Anal Biochem 157:291–294CrossRefPubMed

Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 33:1444–1452PubMed

Narasimhan B, Mourva V, Dhake A (2006) Design, synthesis, antibacterial, and QSAR studies of myristic acid derivatives. Bioorg Med Chem Lett 16:3023–3029CrossRefPubMed

Navarro X, Segura R (1989) Red blood cell fatty acids in multiple sclerosis. Acta Neurol Scand 79:32–37CrossRefPubMed

Okubo K, Hamasaki N, Hara K, Kageura M (1991) Palmitoylation of cysteine 69 from the COOH-terminal of Band 3 protein in the human erythrocyte membrane. J Biol Chem 266:16420–16424PubMed

Sands JA (1977) Inactivation and inhibition of replication of the enveloped bacteriophage φ6 by fatty acids. Antimicrob Agents Chemother 12:523–528PubMed

Stinissen P, Raus J, Zhang J (1997) Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies. Crit Rev Immunol 17:33–75PubMed

Van Jaarsveld PJ, Smuts CM, Tichelaar HY, Kruger M, Benadé AJS (2000) Effect of palm oil on plasma lipoprotein concentrations and plasma low-density lipoprotein composition in non-human primates. Int J Food Sci Nutr 51:S21–S30CrossRefPubMed

Van Meeteren ME, Teunissen CE, Dijkstra CD, Van Tol EA (2005) Antioxidants and polyunsaturated fatty acids in multiple sclerosis. Eur J Clin Nutr 59:1347–61CrossRefPubMed

Warren SA, Warren KG, Greenhill S, Paterson M (1982) How multiple sclerosis is related to animal illness, stress and diabetes. Can Med Assoc J 126:377–385PubMed

Westlund KB, Kurland LT (1953) Studies on multiple sclerosis in Winnipeg, Manitoba, and New Orleans. Louisiana Am J Hyg 57:397–407

Zamaria N (2004) Alteration of polyunsaturated fatty acid status and metabolism in health and disease. Reprod Nutr Dev 44:273–82CrossRefPubMed

Zhang SM, Willett WC, Hernán MA, Olek MJ, Ascherio A (2000) Dietary fat in relation to risk of multiple sclerosis among two large cohorts of women. Am J Epidemiol 152:1056–64CrossRefPubMed

Title: Membrane saturated fatty acids and disease progression in Multiple Sclerosis patients
Authors: G. M. Hon
M. S. Hassan
S. J. van Rensburg
S. Abel
R. T. Erasmus
T. Matsha
Publication date: 01-12-2009
Publisher: Springer US
Published in: Metabolic Brain Disease / Issue 4/2009
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI: https://doi.org/10.1007/s11011-009-9159-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Membrane saturated fatty acids and disease progression in Multiple Sclerosis patients

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2009

Editorial

Exercise increases BDNF levels in the striatum and decreases depressive-like behavior in chronically stressed rats

Changes in erythrocyte membrane fatty acids during a clinical trial of eicosapentaenoic acid (EPA) supplementation in schizophrenia

Acidic vesicles of the endo-exocytic pathways as targets for some anti-monoamine oxidase drugs

Maternal separation alters nerve growth factor and corticosterone levels but not the DNA methylation status of the exon 17 glucocorticoid receptor promoter region

Brain iron homeostasis, the choroid plexus, and localization of iron transport proteins